Articles published by Gilead Sciences, Inc.
Gilead Sciences Launches Choose U™ Campaign Spotlighting the Inspiring Experiences of People Living with HIV
September 04, 2025
Via Business Wire
Tickers
GILD
Gilead Sciences Breaks Ground on New Manufacturing Hub, a Cornerstone of Its U.S. Growth and Innovation Strategy
September 03, 2025
Via Business Wire
Tickers
GILD
European Commission Authorizes Twice-Yearly Yeytuo® (Lenacapavir) for HIV Prevention
August 26, 2025
Via Business Wire
Tickers
GILD
Via Business Wire
Tickers
GILD
Gilead Sciences to Present at Upcoming Investor Conferences
August 20, 2025
Via Business Wire
Tickers
GILD
Gilead Sciences Announces Second Quarter 2025 Financial Results
August 07, 2025
Via Business Wire
Tickers
GILD
Gilead Sciences to Release Second Quarter 2025 Financial Results on Thursday, August 7, 2025
July 24, 2025
Via Business Wire
Tickers
GILD
Gilead Presents New Data on Twice-Yearly Lenacapavir (Yeztugo®) for HIV Prevention at IAS 2025
July 14, 2025
Via Business Wire
Tickers
GILD


Via Business Wire
Tickers
GILD
Via Business Wire
Tickers
GILD
Gilead Sciences to Present at Upcoming Investor Conferences
April 29, 2025
Via Business Wire
Tickers
GILD
Gilead to Present Latest Advancements Across Primary Biliary Cholangitis and Viral Hepatitis
April 29, 2025
Via Business Wire
Tickers
GILD
Via Business Wire
Tickers
GILD
Gilead Sciences to Release First Quarter 2025 Financial Results on Thursday, April 24, 2025
April 10, 2025
Via Business Wire
Tickers
GILD





Gilead Sciences to Present at Upcoming Investor Conferences
February 19, 2025
Via Business Wire
Tickers
GILD
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.